Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-12-27FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
FDA approved a supplemental application for metoprolol succinate (Toprol-XL) under an ANDA from Nivagen Pharmaceuticals.
-
FDA approval · 2023-12-22FDA Approved: TENORETIC — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for Tenoretic, a fixed-dose combination of atenolol and chlorthalidone from Upsher-Smith Laborat…
-
FDA approval · 2023-12-22FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for the bisoprolol fumarate and hydrochlorothiazide combination from Teva Pharmaceuticals USA, I…
-
FDA approval · 2023-12-22FDA Approved: TENORMIN — Supplemental Application (Almatica Pharma LLC)
FDA approves a supplemental application for Tenormin (atenolol) filed by Almatica Pharma LLC.
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of ION904 in Participants With Uncontrolled Hypertension [Phase 2]
Phase 2 trial update evaluating monthly subcutaneous ION904 for safety, tolerability, and efficacy in adults with uncontrolled hypertension;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-12-21FDA Approved: TELMISARTAN — Supplemental Application (Modavar Pharmaceuticals LLC)
The FDA approved a supplemental application for Telmisartan submitted by Modavar Pharmaceuticals LLC, resulting in an updated regulatory app…
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Improving Chronic Disease Management With Pieces [NA]
Completed clinical trial evaluating a program for improving chronic disease management in chronic kidney disease and diabetes.
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of the valsartan/amlodipine combination in hypertensive patients not controlled …
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: The Safety and Efficacy of an NAD+ Boosting Product Together With a Low Carbohydrate Diet in Adults With Mild Hypertension and Eligible for Normal-standard-of-care [Phase 2]
Phase 2 trial evaluating safety and efficacy of an NAD+ boosting product combined with a low-carbohydrate diet in adults with mild hypertens…
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities [Phase 4]
Phase IV trial comparing MICARDIS 80 mg to amlodipine 10 mg assessing biological PPAR gamma activities in hypertension and metabolic syndrom…
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) [Phase 4]
A Phase 4 randomized trial comparing telmisartan to losartan in hypertensive patients with type 2 diabetes and overt nephropathy; completed.
-
FDA approval · 2023-12-06FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for a generic Benazepril hydrochloride and hydrochlorothiazide combination ta…
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN [Phase 4]
Phase 4 trial comparing telmisartan to ramipril using ambulatory blood pressure monitoring in hypertension; completed.
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Intermittent Fasting Adherence and Self Tracking [NA]
A completed clinical trial evaluating intermittent fasting adherence and self-tracking in adults with hypertension and obesity. Results post…
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Blood Pressure in Dialysis Patients [NA]
A completed clinical trial from University of New Mexico on blood pressure management in patients undergoing hemodialysis has posted results…
-
FDA approval · 2023-11-22FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for metoprolol tartrate from Aurobindo Pharma Limited. The action confirms approval of changes to an…
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Controlling and Lowering Blood Pressure With The MOBIUS HD™ (CALM-FIM_EUR) [NA]
Clinical trial update for MOBIUS HD device study CALM-FIM_EUR evaluating blood pressure control in hypertension; study completed with result…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Behavioral Economics to Improve Antihypertensive Therapy Adherence [NA]
Completed clinical trial evaluating behavioral economics approaches to improve adherence to antihypertensive therapy; results posted Novembe…
-
CLINICAL_TRIALS research · 2023-11-18Clinical Trial Update: Genomic Outcomes of Metformin [Phase 4]
A Phase 4 trial assessing genomic outcomes of metformin in adults with coronary artery disease and mild cognitive impairment, with results p…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin [Phase 3]
Phase 3 trial update evaluating efficacy and safety of valsartan alone and in combination with simvastatin for hypertension and hypercholest…
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Piloting Mindfulness Meditation Program for Underserved Racial Minority Adults With Pulmonary Hypertension [NA]
Completed clinical trial piloting a mindfulness meditation program for underserved racial minority adults with pulmonary hypertension; resul…
-
FDA approval · 2023-11-07FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Inderal LA (propranolol hydrochloride) by ANI Pharmaceuticals, Inc. The action confirms regulato…
-
FDA approval · 2023-11-01FDA Approved: CARVEDILOL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's supplemental application for carvedilol, allowing continued marketing of the generic product.
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate [NA]
Clinical trial update on preventing metabolic side effects of thiazide diuretics using KMgCitrate for hypertension; study completed with res…
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia [Phase 3]
Phase 3 trial update for a fixed-dose combination of atorvastatin and perindopril in adults with arterial hypertension and dyslipidemia; stu…